EVGN
EVGN
NASDAQ · Biotechnology

Evogene Ltd

$0.38
-0.04 (-8.59%)
As of Sep 28, 10:42 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +5,584.2% upside
Low Target $19.68
Average Target $21.60
High Target $29.43
Current Price $0.38
Current
$0.38
Target
$21.60
$19.68 $21.60 avg $29.43
Scenario Analysis
Bear Case
$19.68
5,078.9%
Low target
Base Case
$21.60
+5,584.2%
Avg target
Bull Case
$29.43
+7,644.7%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$1.50
-74.7% from high
52-Week Low
$0.37
+2.7% from low
Target vs 52W High
$21.60
+1,340.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%